{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:06:15Z","timestamp":1787612775230,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/50239-6"],"award-info":[{"award-number":["2012\/50239-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00259-020-04714-0","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T22:02:25Z","timestamp":1581631345000},"page":"2666-2680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-4583","authenticated-orcid":false,"given":"Artur Martins","family":"Coutinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo F.","family":"Busatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Henrique","family":"de Gobbi Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"de Paula Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Rachel","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Teles","family":"Garcez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Squarzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Luiz","family":"de Souza Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Okada","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Sturzeneker","family":"Tres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Maria Dozzi","family":"Brucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestes Vicente","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Nitrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Buchpiguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"4714_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"C Jack","year":"2018","unstructured":"Jack C, Bennett D, Blennow K, Carrillo M, Dunn B, Haeberlein S, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"4714_CR2","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC. Rates of \u03b2-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 2014;82(18):1605\u201312.","DOI":"10.1212\/WNL.0000000000000386"},{"key":"4714_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"C Jack","year":"2016","unstructured":"Jack C, Bennett D, Blennow K, Carrillo M, Feldman H, Frisoni G, et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87:539\u201347.","journal-title":"Neurology."},{"key":"4714_CR4","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"Pike","year":"2007","unstructured":"Pike, Savage, Villemagne, Ng, Moss, Maruff, et al. \u03b2-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease. Brain. 2007;130:2837\u201344.","journal-title":"Brain"},{"key":"4714_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","volume":"71","author":"E Mormino","year":"2014","unstructured":"Mormino E, Betensky R, Hedden T, Schultz A, Amariglio R, Rentz D, et al. Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014;71:1379\u201385.","journal-title":"JAMA Neurol"},{"key":"4714_CR6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","volume":"80","author":"T Hedden","year":"2013","unstructured":"Hedden T, Oh H, Younger A, Patel T. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology. 2013;80:1341\u20138.","journal-title":"Neurology"},{"key":"4714_CR7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","volume":"14","author":"D Knopman","year":"2018","unstructured":"Knopman D, Haeberlein S, Carrillo M, Hendrix J, Kerchner G, Margolin R, et al. The National Institute on Aging and the Alzheimer\u2019s Association Research Framework for Alzheimer\u2019s disease: perspectives from the research roundtable. Alzheimer\u2019s Dement. 2018;14:563\u201375.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4714_CR8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"W Klunk","year":"2004","unstructured":"Klunk W, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt D, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"4714_CR9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00259-011-2021-8","volume":"39","author":"Camus","year":"2012","unstructured":"Camus, Payoux, Barr\u00e9, Desgranges, Voisin, Tauber, et al. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging. 2012;39:621\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4714_CR10","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, et al. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46:1959\u201372.","journal-title":"J Nucl Med"},{"key":"4714_CR11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"C Clark","year":"2012","unstructured":"Clark C, Pontecorvo M, Beach T, Bedell B, Coleman R, Doraiswamy P, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol. 2012;11:669\u201378.","journal-title":"Lancet Neurol"},{"key":"4714_CR12","doi-asserted-by":"crossref","unstructured":"La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Dor\u00e9 V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C Jr, Jagust WJ, Jin LW, Klunk WE, Kofler J, Lesman-Segev OH, Lockhart SN, Lowe VJ, Masters CL, Mathis CA, McLean CL, Miller BL, Mungas D, O'Neil JP, Olichney JM, Parisi JE, Petersen RC, Rosen HJ, Rowe CC, Spina S, Vemuri P, Villemagne VL, Murray ME, Rabinovici GD. Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement. 2019;15:205\u2013216.","DOI":"10.1016\/j.jalz.2018.09.001"},{"key":"4714_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2967\/jnumed.117.198325","volume":"59","author":"V Villemagne","year":"2017","unstructured":"Villemagne V. Selective Tau Imaging:Der Stand der Dinge. J Nucl Med. 2017;59:175\u20136.","journal-title":"J Nucl Med"},{"key":"4714_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1148\/radiology.198.3.8628880","volume":"198","author":"M Burdette","year":"1996","unstructured":"Burdette M, Borght V, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology. 1996;198:837\u201343.","journal-title":"Radiology"},{"key":"4714_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey K, Foster N, Kuhl D. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann Neurol. 1997;42:85\u201394.","journal-title":"Ann Neurol"},{"key":"4714_CR16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol I. 2003;30:1104\u201313.","journal-title":"Eur J Nucl Med Mol I"},{"key":"4714_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nicl.2014.12.004","volume":"7","author":"C Cerami","year":"2015","unstructured":"Cerami C, Rosa P, Magnani G, Santangelo R, Marcone A, Cappa S, et al. Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. Neuroimage Clin. 2015;7:187\u201394.","journal-title":"Neuroimage Clin"},{"key":"4714_CR18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuroimage.2012.03.091","volume":"63","author":"P-J Toussaint","year":"2012","unstructured":"Toussaint P-J, Perlbarg V, Bellec P, Desarnaud S, Lacomblez L, Doyon J, et al. Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer\u2019s disease using conjoint univariate and independent component analyses. Neuroimage. 2012;63:936\u201346.","journal-title":"Neuroimage"},{"key":"4714_CR19","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"D Silverman","year":"2001","unstructured":"Silverman D, Small G, Chang C, Lu C, de Aburto M, Chen W, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286:2120\u20137.","journal-title":"JAMA"},{"key":"4714_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00259-015-3170-y","volume":"43","author":"D Perani","year":"2016","unstructured":"Perani D, Cerami C, Caminiti S, Santangelo R, Coppi E, Ferrari L, et al. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging. 2016;43:499\u2013508.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4714_CR21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneurol.2009.59","volume":"66","author":"E Petrie","year":"2009","unstructured":"Petrie E, Cross D, Galasko D, Schellenberg G, Raskind M, Peskind E, et al. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Arch Neurol. 2009;66:632\u20137.","journal-title":"Arch Neurol"},{"key":"4714_CR22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2012.07.003","volume":"9","author":"R Ossenkoppele","year":"2013","unstructured":"Ossenkoppele R, Prins N, Pijnenburg Y, Lemstra A, van der Flier W, Adriaanse S, et al. Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers Dement. 2013;9:414\u201321.","journal-title":"Alzheimers Dement"},{"key":"4714_CR23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"G McKhann","year":"2011","unstructured":"McKhann G, Knopman D, Chertkow H, Hyman B, Jack C, Kawas C, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4714_CR24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/S1516-44462001000300008","volume":"23","author":"C Del-Ben","year":"2001","unstructured":"Del-Ben C, Vilela J, Crippa J, Hallak J, Labate C, Zuardi A. Confiabilidade da \u201cEntrevista Cl\u00ednica Estruturada para o DSM-IV - Vers\u00e3o Cl\u00ednica\u201d traduzida para o portugu\u00eas. Rev Bras Psiquiatr. 2001;23:156\u20139.","journal-title":"Rev Bras Psiquiatr"},{"key":"4714_CR25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","volume":"144","author":"G Blessed","year":"1968","unstructured":"Blessed G, Tomlinson B, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;144:797\u2013811.","journal-title":"Br J Psychiatry"},{"key":"4714_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"M Folstein","year":"1975","unstructured":"Folstein M, Foltstein S, McHugh P. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"4714_CR27","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1056\/NEJMcp0910237","volume":"364","author":"RC Petersen","year":"2011","unstructured":"Petersen RC. Mild cognitive impairment. N Engl J Med. 2011;364:2234.","journal-title":"N Engl J Med"},{"key":"4714_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"M Albert","year":"2011","unstructured":"Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139.","journal-title":"Alzheimers Dement."},{"key":"4714_CR29","unstructured":"ABA. Crit\u00e9rio de classifica\u00e7\u00e3o s\u00f3cio-econ\u00f4mica. 2007. http:\/\/www.aba.com.br\/wp-content\/uploads\/content\/7727632a373615b34f2a5726fcc5c9e2.pdf - content in portuguese). Assessed 7 Mar 2018."},{"key":"4714_CR30","doi-asserted-by":"crossref","unstructured":"Faria DP, Duran FL, Squarzoni P, Coutinho AM, Garcez AT, Santos PP, Brucki SM, de Oliveira MO, Tr\u00e9s ES, Forlenza OV, Nitrini R, Buchpiguel CA, Busatto Filho G. Topography of 11C-Pittsburgh compound B uptake in Alzheimer's disease: a voxel-based investigation of cortical and white matter regions. Braz J Psychiatry. 2019;41:101-111.","DOI":"10.1590\/1516-4446-2017-0002"},{"key":"4714_CR31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s00259-016-3591-2","volume":"44","author":"T Yamane","year":"2017","unstructured":"Group J-A, Yamane T, Ishii K, Sakata M, Ikari Y, Nishio T, et al. Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer\u2019s Disease Neuroimaging Initiative (J-ADNI) multicenter study. Eur J Nucl Med Mol Imaging. 2017;44:850\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4714_CR32","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/aww160","volume":"139","author":"A Leuzy","year":"2016","unstructured":"Leuzy A, Chiotis K, Hasselbalch S, Rinne J, Mendon\u00e7a A, Otto M, et al. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-\u03b2 in a multicentre European memory clinic study. Brain. 2016;139:2540\u201353.","journal-title":"Brain"},{"key":"4714_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe R, Price J, Benzinger T, Devous M, Jagust W, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1\u201315.e4.","journal-title":"Alzheimers Dement"},{"key":"4714_CR34","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes DA, Petersen RC. Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimers Dement. 2017;13:205-21.","DOI":"10.1016\/j.jalz.2016.08.005"},{"key":"4714_CR35","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","volume":"138","author":"S Villeneuve","year":"2015","unstructured":"Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain. 2015;138:2020\u201333.","journal-title":"Brain"},{"key":"4714_CR36","doi-asserted-by":"publisher","unstructured":"Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging\u2013Alzheimer\u2019s Association Research Framework. JAMA Neurol. 2019. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1971.","DOI":"10.1001\/jamaneurol.2019.1971"},{"key":"4714_CR37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","volume":"49","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Tsui W, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias. J Nucl Med. 2008;49:390\u20138.","journal-title":"J Nucl Med"},{"key":"4714_CR38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","volume":"39","author":"A Drzezga","year":"2008","unstructured":"Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, et al. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer\u2019s disease. Neuroimage. 2008;39:619\u201333.","journal-title":"Neuroimage"},{"key":"4714_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2008.07.015","volume":"44","author":"I Yakushev","year":"2009","unstructured":"Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz H-G, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer\u2019s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage. 2009;44:43\u201350.","journal-title":"Neuroimage"},{"key":"4714_CR40","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.neuroimage.2009.09.017","volume":"49","author":"J Dukart","year":"2010","unstructured":"Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage. 2010;49:1490\u20135.","journal-title":"Neuroimage"},{"key":"4714_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2012.11.026","volume":"534","author":"A K\u00fcntzelmann","year":"2013","unstructured":"K\u00fcntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, et al. Impaired cerebral glucose metabolism in prodromal Alzheimer\u2019s disease differs by regional intensity normalization. Neurosci Lett. 2013;534:12\u20137.","journal-title":"Neurosci Lett"},{"key":"4714_CR42","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238\u201348.","journal-title":"J Nucl Med"},{"key":"4714_CR43","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","volume":"25","author":"L Teune","year":"2010","unstructured":"Teune L, Bartels A, de Jong B, Willemsen A, Eshuis S, de Vries J, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord. wiley. 2010;25:2395\u2013404.","journal-title":"Mov Disord"},{"key":"4714_CR44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"P Harris","year":"2009","unstructured":"Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"4714_CR45","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","volume":"6","author":"RA Sperling","year":"2014","unstructured":"Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, et al. The A4 study: stopping AD before symptoms begin? Sci Transl Med. 2014;6:228fs13.","journal-title":"Sci Transl Med"},{"key":"4714_CR46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","volume":"83","author":"C Dyck","year":"2018","unstructured":"Dyck C. Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise. Biol Psychiatry. 2018;83:311\u20139.","journal-title":"Biol Psychiatry"},{"key":"4714_CR47","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","volume":"321","author":"G Rabinovici","year":"2019","unstructured":"Rabinovici G, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, et al. Association of Amyloid Positron Emission Tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321:1286\u201394.","journal-title":"JAMA"},{"key":"4714_CR48","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","volume":"73","author":"L Wang","year":"2016","unstructured":"Wang L, Benzinger T, Su Y, Christensen J, Friedrichsen K, Aldea P, et al. Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between \u03b2-amyloid and tauopathy. Jama Neurol. 2016;73:1070.","journal-title":"Jama Neurol"},{"key":"4714_CR49","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jalz.2019.07.010","volume":"15","author":"K McRae-McKee","year":"2019","unstructured":"McRae-McKee K, Udeh-Momoh CT, Price G, Bajaj S, de Jager CA, et al. Perspective: clinical relevance of the dichotomous classification of Alzheimer\u2019s disease biomarkers: should there be a \u201cgray zone\u201d? Alzheimers Dement. 2019;15:1348\u201356.","journal-title":"Alzheimers Dement"},{"key":"4714_CR50","first-page":"1","volume":"00","author":"R Ismail","year":"2019","unstructured":"Ismail R, Parbo P, Hansen KV, Schaldemose JL, Dalby RB, Tietze A, et al. Abnormal amyloid load in mild cognitive impairment: the effect of reducing the PiB-PET threshold. J Neuroimaging. 2019;00:1\u20137.","journal-title":"J Neuroimaging"},{"key":"4714_CR51","first-page":"594","volume":"45","author":"D Silverman","year":"2004","unstructured":"Silverman D. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med. 2004;45:594\u2013607.","journal-title":"J Nucl Med"},{"key":"4714_CR52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"S Landau","year":"2011","unstructured":"Landau S, Harvey D, Madison C, Koeppe R, Reiman E, Foster N, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011;32:1207\u201318.","journal-title":"Neurobiol Aging"},{"key":"4714_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-015-0143-0","volume":"7","author":"A Coutinho","year":"2015","unstructured":"Coutinho A, Porto F, Duran F, Prando S, Ono C, Feitosa E, et al. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects. Alzheimers Res Ther. 2015;7:1\u201310.","journal-title":"Alzheimers Res Ther"},{"key":"4714_CR54","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archneurol.2010.280","volume":"67","author":"M Murray","year":"2010","unstructured":"Murray M, Senjem M, Petersen R, Hollman J, Preboske G, Weigand S, et al. Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol. 2010;67:1379\u201385.","journal-title":"Arch Neurol"},{"key":"4714_CR55","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.61.10.1545","volume":"61","author":"B Reed","year":"2004","unstructured":"Reed B, Eberling J, Mungas D, Weiner M, Kramer J, Jagust W. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61:1545\u201350.","journal-title":"Arch Neurol"},{"key":"4714_CR56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","volume":"131","author":"C Jack","year":"2008","unstructured":"Jack C, Lowe V, Senjem M, Weigand S, Kemp B, Shiung M, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment. Brain. 2008;131:665\u201380.","journal-title":"Brain"},{"key":"4714_CR57","first-page":"208","volume":"25","author":"GA Jicha","year":"2019","unstructured":"Jicha GA, Nelson PT. Hippocampal sclerosis, argyrophilic grain disease, and primary age-related tauopathy. Continuum (Minneap Minn). 2019;25:208\u201333.","journal-title":"Continuum (Minneap Minn)"},{"key":"4714_CR58","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR Jr, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503\u201327.","journal-title":"Brain"},{"key":"4714_CR59","doi-asserted-by":"crossref","first-page":"e1002334","DOI":"10.1371\/journal.pmed.1002334","volume":"14","author":"J Rusmaully","year":"2017","unstructured":"Rusmaully J, Dugravot A, Moatti JP, Marmot MG, Elbaz A, Kivimaki M, et al. Contribution of cognitive performance and cognitive decline to associations between socioeconomic factors and dementia: a cohort study. PLoS Med. 2017;14:e1002334.","journal-title":"PLoS Med"},{"key":"4714_CR60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.psychres.2011.11.012","volume":"196","author":"C Sattler","year":"2012","unstructured":"Sattler C, Toro P, Sch\u00f6nknecht P, Schr\u00f6der J. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer\u2019s disease. Psychiatry Res. 2012;196:90\u2013952011.","journal-title":"Psychiatry Res"},{"key":"4714_CR61","doi-asserted-by":"crossref","first-page":"e025602","DOI":"10.1136\/bmjopen-2018-025602","volume":"9","author":"CE Schwartz","year":"2019","unstructured":"Schwartz CE, Zhang J, Stucky BD, Michael W, Rapkin BD. Is the link between socioeconomic status and resilience mediated by reserve-building activities: mediation analysis of web-based cross-sectional data from chronic medical illness patient panels. BMJ Open. 2019;9:e025602.","journal-title":"BMJ Open"},{"key":"4714_CR62","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11:1006\u201312.","journal-title":"Lancet Neurol"},{"key":"4714_CR63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/156720511795745320","volume":"8","author":"AM Tucker","year":"2011","unstructured":"Tucker AM, Stern Y. Cognitive reserve in aging. Curr Alzheimer Res. 2011;8:354\u201360.","journal-title":"Curr Alzheimer Res"},{"key":"4714_CR64","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/01.wnl.0000327670.62378.c0","volume":"71","author":"Garibotto","year":"2008","unstructured":"Garibotto, Borroni, Kalbe, Herholz, Salmon. Education and occupation as proxies for reserve in aMCI converters and AD FDG-PET evidence. Neurology. 2008;71:1342\u20139.","journal-title":"Neurology"},{"key":"4714_CR65","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1212\/WNL.0b013e31828970c2","volume":"80","author":"M Ewers","year":"2013","unstructured":"Ewers M, Insel P, Stern Y, Weiner M. (ADNI) F. Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology. 2013;80:1194\u2013201.","journal-title":"Neurology"},{"key":"4714_CR66","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00259-019-04342-3","volume":"46","author":"MC Hoenig","year":"2019","unstructured":"Hoenig MC, Bischof GN, Onur OA, Kukolja J, Jessen F, Fliessbach K, et al. Level of education mitigates the impact of tau pathology on neuronal function. Eur J Nucl Med Mol Imaging. 2019;46:1787\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"}],"updated-by":[{"DOI":"10.1007\/s00259-020-04933-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000}}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04714-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-020-04714-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04714-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:30:09Z","timestamp":1613089809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-020-04714-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4714"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04714-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00259-020-04933-5","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the last paragraph of the subsession \u201cRecruitment of the study population and clinical Evaluation\u201d (Material and methods session).","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Artur Martins Coutinho declares that he has no conflicts of interest.F\u00e1bio Henrique de Gobbi Porto has received a speaker honorarium from Libbs, Lundbeck, and Sandoz-Novartis.Daniele de Paula Faria declares that she has no conflicts of interest.Carla Rachel Ono declares that she has no conflicts of interest.Alexandre Teles Garcez declares that he has no conflicts of interest.Paula Squarzoni declares that she has no conflicts of interest.F\u00e1bio Luiz de Souza Duran declares that he has no conflicts of interest.Maira Okada de Oliveira declares that she has no conflicts of interest.Eduardo Sturzeneker Tres declares that he has no conflicts of interest.Sonia Maria Dozzi Brucki declares that she has no conflicts of interest.Orestes Vicente Forlenza declares that he has no conflicts of interest.Ricardo Nitrini declares that he has no conflicts of interest.Geraldo Busatto Filho declares that he has no conflicts of interest.Carlos Alberto Buchpiguel declares that he has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}